Blog
RSS FeedPosted by Michael Wonder on 10 Jan 2018
Ontario has added Erelzi (etanercept) to public drug plan for the treatment of multiple inflammatory diseases
9 January 2018 - Erelzi has been added to public drug plan based on specific criteria in Ontario for the treatment ...
Posted by Michael Wonder on 29 Dec 2017
Montreal woman with ALS fights for Canadian access to new drugs
28 December 2017 - 'Please help us get access. ALS is a fatal disease and it goes fast,' Montrealer Nancy Roch ...
Posted by Michael Wonder on 18 Dec 2017
Melissa’s battle hurts
17 December 2017 - Residents urged to pressure government to help Vernon woman gain access to life-saving medication. ...
Posted by Michael Wonder on 13 Dec 2017
Edmonton woman begs Alberta to cover life-changing $250K cystic fibrosis drug
12 December 2017 - At 25 years old, cystic fibrosis patient Katrina Secord says her fate is in the hands ...
Posted by Michael Wonder on 13 Dec 2017
Update on revised process for biosimilars
12 December 2017 - In August 2017, CADTH invited stakeholder comments and feedback on a proposal to revise the submission and ...
Posted by Michael Wonder on 11 Dec 2017
Call for feedback: medicine for the management of rheumatoid arthritis
9 December 2017 - A draft report on medicine for the management of rheumatoid arthritis is now available for feedback from ...
Posted by Michael Wonder on 05 Dec 2017
Canada's regulator of patented drug prices is rigging data, and risking our health
5 December 2017 - The patent medicine pricing board is making a blatant attempt to bias the data. ...
Posted by Michael Wonder on 04 Dec 2017
Brand name drug sales soar in Canada, while R&D sags
1 December 2017 - Patented drug industry disputes it's failing to invest enough into research and development. ...
Posted by Michael Wonder on 04 Dec 2017
Prescription drug costs should be fair – not cheap
4 December 2017 - "Canadians are not getting the value for money on prescription medicine spending or the outcomes they ...
Posted by Michael Wonder on 03 Dec 2017
Ottawa unveils new draft regulations for drug-pricing
2 December 2017 - The Trudeau government is plowing ahead with an overhaul of the country's drug-pricing rules, unveiling draft ...
Posted by Michael Wonder on 30 Nov 2017
New report reveals need for a gender-based approach to health funding for women to have full economic empowerment
30 November 2017 - Recent CADTH recommendation to improve access to oral uterine fibroids treatment presents positive step forward in helping ...
Posted by Michael Wonder on 27 Nov 2017
Revised process for filing CDR submissions and resubmissions
27 November 2017 - The CADTH Common Drug Review is aligning the process for secure file sharing with the pan-Canadian ...
Posted by Michael Wonder on 24 Nov 2017
A check-up on Canada's health care system
25 November 2017 - In 2005, one of us (KMW) watched a close friend go in and out of hospital in ...
Posted by Michael Wonder on 23 Nov 2017
Canada-wide program aims to get young cancer patients faster access to new therapies
23 November 2017 - If Terry Fox were diagnosed today, he would fall among the 20 per cent of young ...
Posted by Michael Wonder on 16 Nov 2017
Industry fees are applicable to all CDR resubmissions
13 November 2017 - All resubmissions that are filed by manufacturers on or after 2 January 2018 will be subject to ...